Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: Potential problems in interpretation of folate bioavailability studies

British Journal of Nutrition

Volumn 90, Issue 2, 2003, Pages 363-371

  Wright, A J A ^a   Finglas, Paul M ^a   Dainty, J R ^a   Hart, D J ^a   Wolfe, C A ^a   Southon, S ^a   Gregory, J F ^b  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Absorption; Folate; Plasma; Pteroylmonoglutamic acid; Stable isotopes

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; CARBON 13; FOLIC ACID; FOLINIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BINDING AFFINITY; BIOAVAILABILITY; BLOOD ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KINETICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEMBRANE TRANSPORT; METHYLATION; NORMAL HUMAN; OUTCOMES RESEARCH; PLASMA CLEARANCE; TEST MEAL; VITAMIN METABOLISM;

ABSORPTION; ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; CARBON ISOTOPES; CROSS-OVER STUDIES; FEMALE; FORMYLTETRAHYDROFOLATES; HUMANS; MALE; PTEROYLPOLYGLUTAMIC ACIDS; TETRAHYDROFOLATES;

EID: 0042062309     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2003908     Document Type: Article

References (38)

1. Anonymous (1991) Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338, 131-137.
2. Bailey LB, Barton LE, Hillier SE & Cerda JJ (1988) Bioavailability of mono and polyglutamyl folate in human subjects. Nutr Rep Int 38, 509-518.
3. Bhandari SD & Gregory JF (1992) Folic acid 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J Nutr 122, 1847-1854.
4. Blakley RL (1969) The biochemistry of folic acid and related pteridines. In Frontiers of Biology, vol. 13, pp. 92-94 [A Neuberger and EL Tatum, editors]. London: North-Holland.
5. Blount BC, Mack MM & Wehr CM, et al. (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acadi Sci USA 94, 3290-3295.
6. Bousey CJ, Beresford SA, Omenn GS & Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease - Probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057.
7. Bower C, Stanley FJ, Croft M, De Clerk NH, Davis RE & Nicol DJ (1993) Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Br J Nutr 69, 827-834.
8. Brown JP, Scott JM, Foster FG & Weir DG (1973) Ingestion and absorption of naturally occurring pteroylmonoglutamates (folates) in man. Gastroenterology 64, 223-232.
9. 14C-folic acid. Adv Exp Med Biol 445, 239-251.
10. Czeizel AE & Dudas I (1992) Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. N Engl J Med 327, 32-35.
11. Fenech M, Noakes N, Clifton P & Topping D (1999) Aleurone flour is a rich source of bioavailable folate in humans. J Nutr 129, 1114-1119.
12. Finglas PM, Dainty JR, Hart D, Wolfe C, Wright AJ, Wright D, Southon S & Gregory JF (2002a) Modelling of labelled absorbed folates using plasma in humans. FASEB J 16, A748.
13. Finglas PM, Witthöft CM, Vahteristo L, et al. (2002b) Use of an oral/intravenous dual-label stable-isotope protocol to determine folic acid bioavailability from fortified cereal grain foods in women. J Nutr 132, 936-939.
14. 2] folic acid: Extent and specificity of deuterium labelling. J Agric Food Chem 38, 1073-1076.
15. Gregory JF (1997) Bioavailability of folate. Eur J Clin Nutr 51, Suppl. 1, S54-S59.
16. Gregory JF (2001) Case study: Folate bioavailability. J Nutr 131, Suppl. 4, 1376S-1382S.
17. Gregory JF, Bhandari SD, Bailey LB, Toth JP, Baumgartner TG & Cerda JJ (1992) Relative bioavailability of deuterium-labeled monoglutamyl tetrahydrofolates and folic acid in human subjects. Am J Clin Nutr 55, 1147-1153.
18. Hart DJ, Finglas PM, Wolfe CA, Mellon F, Wright AJA & Southon S (2002) Determination of 5-methyltetrahydrofolate (13C-labelled and unlabelled) in human plasma and urine by combined liquid chromatography mass spectrometry (LC/MS). Anal Biochem 305, 206-213.
19. Kelly P, McPartlin J, Goggins M, Weir DG & Scott JM (1997) Unmetabolized folic acid in serum: Acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 65, 1790-1795.
20. Lucock MD, Wild J, Smithells RW & Hartley R (1989) In vivo characterization of the absorption and biotransformation of pteroylmonoglutamic acid in man: A model for future studies. Biochem Med Metab Biol 42, 30-42.
21. Markkanen T (1968) Absorption tests with natural folate material in controls and in gastrectomized patients. Am J Clin Nutr 21, 473-481.
22. Mathews CK & Huennekens FM (1963) Further studies on dihydrofolate reductase. J Biol Chem 238, 3436-3442.
23. Maunder P, Finglas PM, Mallet AI, Mellon FA, Razzaque MA, Ridge B, Vahteristo L & Witthöft C (1999) The synthesis of folic acid, multiply labelled with stable isotopes, for bioavailability studies in human nutrition. J Chem Soc Perkin Trans 1, 1311-1323.
24. 2H-. Meth Enzymol 122, 309-313.
25. Nephew KP & Huang TH-M (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190, 125-133.
26. Perry J (1971) Folate analogues in normal mixed diets. Br J Nutr 21, 435-441.
27. Perry J & Chanarin I (1970) Intestinal absorption of reduced folate compounds in man. Br J Haematol 18, 329-339.
28. Perry J & Chanarin I (1972) Observations on folate absorption with particular reference to folate polyglutamate and possible inhibitors to its absorption. Gut 13, 544-550.
29. Pietrzik K, Hages M & Remer T (1990) Methodological aspects in vitamin bioavailability testing. J Micronutr Anal 7, 207-222.
30. Prinz-Langenohl R, Bronstrup A, Thorad B, Hages M & Pietrzik K (1999) Availability of food folate in humans. J Nutr 129, 913-916.
31. Rogers LM, Pfeiffer CM, Bailey LB & Gregory JF (1997) A dual-label stable-isotopic protocol is suitable for determination of folate bioavailability: Evaluation of urinary excretion and plasma folate kinetics of intravenous and oral doses of [13C5] and [2H2]folic acid. J Nutr 127, 2321-2327.
32. Scott JM & Weir DG (1976) Folate composition, synthesis and function in natural materials. Clinics in Haematology 5, 547-568.
33. Seager H, Aulton ME & Morton FSS (1988) Drug delivery systems; Soft gelatin capsules. In: Pharmaceutics. The Science of Dosage Form Design, pp. 330-340. [ME Aulton, editor]. London: Churchill Livingstone.
34. Selhub J, Dhar GJ & Rosenberg IH (1983) Gastrointestinal absorption of folates and antifolates. Pharmacol Ther 20, 397-418.
35. Shane B (1995) Folate chemistry and metabolism. In Folate in Health and Disease, pp. 1-22. [LB Bailey, editor]. New York, NY: Marcel Dekker.
36. Steinberg SE, Campbell CL & Hillman RS (1979) Kinetics of the normal folate enterohepatic cycle. J Clin Invest 64, 83-88.
37. Van Den Berg H, Finglas PM & Bates C (1994) FLAIR intercomparisons on serum and red cell folate. Int J Vitam Nutr Res 64, 288-293.
38. Wolfe CA, Finglas PM, Hart D, Wright AJA & Southon S (2001) Isotopic methods to detect food folates. Innovat Food Sci Emerg Technol 1, 297-302.